Balz Hersberger

Balz Hersberger is a seasoned professional with a strong background in the pharmaceutical and healthcare industry.

He holds an MBA in General Management from the University of Strathclyde, showcasing his commitment to continuous learning and professional development.

Currently, Balz Hersberger serves as the Director of the Business Unit Obesity at Novo Nordisk Pharma AG, where he brings his wealth of experience and expertise to drive business growth and innovation.

His previous roles at Novo Nordisk Health Care AG, including Director of Sales Innovation and Senior Sales Innovation Manager in International Operations, demonstrate his progressive career within the organization.

Balz Hersberger's experience also extends to roles at Elanco and Novartis Animal Health Inc., where he held various leadership positions such as Sales Force Excellence Leader, Head Middle East Africa, and Business Franchise Manager, showcasing his ability to navigate diverse markets and deliver results.

His tenure at Tillotts Pharma AG as Deputy Sales & Marketing Director further highlights his leadership skills and strategic capabilities in the pharmaceutical sector.

With a track record of success in driving sales, marketing, and business development initiatives, Balz Hersberger is a results-oriented professional with a proven ability to lead teams and achieve organizational objectives.

His extensive experience in the Middle East, North Africa, Europe, and other regions positions him as a global leader with a deep understanding of international markets and customer dynamics.

Balz Hersberger's strategic approach to sales innovation, marketing techniques, and business expansion sets him apart as a dynamic professional capable of driving growth in competitive environments.